Use of Monte Carlo Simulations to Select Therapeutic Doses and Provisional Breakpoints of BAL9141
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.48.5.1713-1718.2004
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2004
Authors
Publisher
American Society for Microbiology